Role of myeloid cells in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease is a broad term for liver conditions not associated with alcohol consumption, and is common around the world. Its initial stage might progress to non-alcoholic hepatitis, cirrhosis or hepatocellular carcinoma, leading in severe cases to liver transplantation. Hepatic myeloid cells including mononuclear phagocytes might play a critical role in activating the immune system and leading to inflammation. The EU-funded project will study the heterogeneity of hepatic mononuclear phagocytes to elucidate roles of their subtypes in the development and progression of non-alcoholic fatty liver disease. Single cell technologies and several modern in vivo tools will be used to understand the significance of the phenotypic and functional heterogeneity of myeloid cells in mice and men.
Fields of science
Funding SchemeERC-STG - Starting Grant
9052 Zwijnaarde - Gent
See on map